Literature DB >> 31107820

Defining a Willingness-to-transplant Threshold in an Era of Organ Scarcity: Simultaneous Liver-kidney Transplant as a Case Example.

Xingxing S Cheng1, Jeremy Goldhaber-Fiebert2, Jane C Tan1, Glenn M Chertow1, W Ray Kim3, Anji E Wall4.   

Abstract

BACKGROUND: Organ scarcity continues in solid organ transplantation, such that the availability of organs limits the number of people able to benefit from transplantation. Medical advancements in managing end-stage organ disease have led to an increasing demand for multiorgan transplant, wherein a patient with multiorgan disease receives >1 organ from the same donor. Current allocation schemes give priority to multiorgan recipients compared with single-organ transplant recipients, which raise ethical questions regarding equity and utility.
METHODS: We use simultaneous liver and kidney (SLK) transplant, a type of multiorgan transplant, as a case study to examine the tension between equity and utility in multiorgan allocation. We adapt the health economics willingness-to-pay threshold to a solid organ transplant setting by coining a new metric: the willingness-to-transplant (WTT) threshold.
RESULTS: We demonstrate how the WTT threshold can be used to evaluate different SLK allocation strategies by synthesizing utility and equity perspectives.
CONCLUSIONS: We submit that this new framework enables us to distill the question of SLK allocation down to: what is the minimum amount of benefit we require from a deceased donor kidney to allocate it for a particular indication? Addressing the above question will prove helpful to devising a rational system of SLK allocation and is applicable to other transplant settings.

Entities:  

Mesh:

Year:  2020        PMID: 31107820      PMCID: PMC6856420          DOI: 10.1097/TP.0000000000002788

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   5.385


  18 in total

1.  An Efficient, Noniterative Method of Identifying the Cost-Effectiveness Frontier.

Authors:  Sze-chuan Suen; Jeremy D Goldhaber-Fiebert
Journal:  Med Decis Making       Date:  2015-04-29       Impact factor: 2.583

2.  Propensity score-based survival benefit of simultaneous liver-kidney transplant over liver transplant alone for recipients with pretransplant renal dysfunction.

Authors:  Pratima Sharma; Xu Shu; Douglas E Schaubel; Randall S Sung; John C Magee
Journal:  Liver Transpl       Date:  2016-01       Impact factor: 5.799

3.  Outcomes of liver transplantation alone after listing for simultaneous kidney: comparison to simultaneous liver kidney transplantation.

Authors:  Bashar Hmoud; Yong-Fang Kuo; Russell H Wiesner; Ashwani K Singal
Journal:  Transplantation       Date:  2015-04       Impact factor: 4.939

4.  Simultaneous Liver Kidney Transplant (SLK) Allocation Policy Change Proposal: Is It Really a Smart Move?

Authors:  H M Wadei; T A Gonwa; C B Taner
Journal:  Am J Transplant       Date:  2016-06-09       Impact factor: 8.086

Review 5.  On the Estimation of the Cost-Effectiveness Threshold: Why, What, How?

Authors:  Laura Vallejo-Torres; Borja García-Lorenzo; Iván Castilla; Cristina Valcárcel-Nazco; Lidia García-Pérez; Renata Linertová; Elena Polentinos-Castro; Pedro Serrano-Aguilar
Journal:  Value Health       Date:  2016-04-23       Impact factor: 5.725

6.  Revisiting multi-organ transplantation in the setting of scarcity.

Authors:  P P Reese; R M Veatch; P L Abt; S Amaral
Journal:  Am J Transplant       Date:  2014-01       Impact factor: 8.086

7.  Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant.

Authors:  R A Wolfe; V B Ashby; E L Milford; A O Ojo; R E Ettenger; L Y Agodoa; P J Held; F K Port
Journal:  N Engl J Med       Date:  1999-12-02       Impact factor: 91.245

8.  External validation of the estimated posttransplant survival score for allocation of deceased donor kidneys in the United States.

Authors:  P A Clayton; S P McDonald; J J Snyder; N Salkowski; S J Chadban
Journal:  Am J Transplant       Date:  2014-06-05       Impact factor: 8.086

9.  Simultaneous liver kidney transplantation: a medical decision analysis.

Authors:  Bryce Kiberd; Chris Skedgel; Ian Alwayn; Kevork Peltekian
Journal:  Transplantation       Date:  2011-01-15       Impact factor: 4.939

10.  Comparing Simultaneous Liver-Kidney Transplant Strategies: A Modified Cost-Effectiveness Analysis.

Authors:  Xingxing S Cheng; W Ray Kim; Jane C Tan; Glenn M Chertow; Jeremy Goldhaber-Fiebert
Journal:  Transplantation       Date:  2018-05       Impact factor: 4.939

View more
  5 in total

1.  Striking a Balance in Simultaneous Heart Kidney Transplant: Optimizing Outcomes for All Wait-Listed Patients.

Authors:  Brian I Shaw; Debra L Sudan; L Ebony Boulware; Lisa M McElroy
Journal:  J Am Soc Nephrol       Date:  2020-06-04       Impact factor: 10.121

2.  Optimal patient selection for simultaneous heart-kidney transplant: A modified cost-effectiveness analysis.

Authors:  Brian Wayda; Xingxing S Cheng; Jeremy D Goldhaber-Fiebert; Kiran K Khush
Journal:  Am J Transplant       Date:  2021-11-30       Impact factor: 8.086

3.  Is Prioritization of Kidney Allografts to Combined Liver-Kidney Recipients Appropriate? CON.

Authors:  Xingxing S Cheng
Journal:  Kidney360       Date:  2021-10-15

4.  The Impact of the 2017 Kidney Allocation Policy Change on Simultaneous Liver-Kidney Utilization and Outcomes.

Authors:  Mariya L Samoylova; Kara Wegermann; Brian I Shaw; Samuel J Kesseli; Sandra Au; Christine Park; Samantha E Halpern; Scott Sanoff; Andrew S Barbas; Yuval A Patel; Debra L Sudan; Carl Berg; Lisa M McElroy
Journal:  Liver Transpl       Date:  2021-07-14       Impact factor: 6.112

5.  Need for improvements in simultaneous heart-kidney allocation: The limitation of pretransplant glomerular filtration rate.

Authors:  Brian I Shaw; Mariya L Samoylova; Scott Sanoff; Andrew S Barbas; Debra L Sudan; L Ebony Boulware; Lisa M McElroy
Journal:  Am J Transplant       Date:  2021-02-09       Impact factor: 9.369

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.